Top PGx Reporter Stories of 2012 Highlight Increasing Challenges of Personalized Medicine Market | GenomeWeb

In 2012, PGx Reporter readers were most interested in stories that reflected the growing complexity of the personalized medicine market.

PGx Reporter's most read stories last year discussed incentives affecting adoption of molecular technologies; tracked the emerging regulatory framework for drug/test combination products; chronicled the changing landscape for gene patents; and followed how life sciences companies are changing their business strategies to focus more on developing products for individualized care.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.